These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 4144627)
1. The influence of lipophilicity on the antibacterial activity of rifamycins. Pelizza G; Lancini GC; Allievi GC; Gallo GG Farmaco Sci; 1973; 28(4):298-315. PubMed ID: 4144627 [No Abstract] [Full Text] [Related]
2. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals]. Shorin VA; Shapovalova SP; Malkova IV Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605 [No Abstract] [Full Text] [Related]
3. Oximes of 3-formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties. Cricchio R; Lancini G; Tamborini G; Sensi P J Med Chem; 1974 Apr; 17(4):396-403. PubMed ID: 4151507 [No Abstract] [Full Text] [Related]
4. [Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study]. Beeuwkes H; Buytendijk HJ; Maesen FP Arzneimittelforschung; 1969 Aug; 19(8):1283-5. PubMed ID: 4390183 [No Abstract] [Full Text] [Related]
5. Evaluation of clinical and antibacterial activity of pyrrolidinemethyltetracycline. Sadowski Z; Krasiejko I Mater Med Pol; 1972; 4(2):71-6. PubMed ID: 4147372 [No Abstract] [Full Text] [Related]
6. The influence of the carboxyl group upon the antibacterial activity of rifamycins. Maggi N; Füresz S; Sensi P J Med Chem; 1968 Mar; 11(2):368-9. PubMed ID: 4969611 [No Abstract] [Full Text] [Related]
7. [Gentamicin susceptibility of gram-negative problem germs and staphylococci, indicated by the tube dilution method]. Modde H Pathol Microbiol (Basel); 1972; 38(4):286-95. PubMed ID: 4565703 [No Abstract] [Full Text] [Related]
8. [Biologically active analogues of dihydrostreptomycin, not containing guanidine groups, synthesized on the basis of dideguanylhydrostreptomycin]. Lazareva EN; Golubev VN; Shneerson AN; Vasilenko OS Antibiotiki; 1968 Aug; 13(8):682-6. PubMed ID: 4176822 [No Abstract] [Full Text] [Related]
9. [Study of antibacterial and antifungal activity of lutenurine in experiments in vitro]. Vichkanova SA; Adgina VV; Fedorchenko TS; Rudinchik MA Farmakol Toksikol; 1969; 32(5):620-3. PubMed ID: 4391463 [No Abstract] [Full Text] [Related]
10. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV]. Shorin VA; Shapovalova SP Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904 [No Abstract] [Full Text] [Related]
12. The antibacterial activity of a new 3-azinomethyl-rifamycin. Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199 [TBL] [Abstract][Full Text] [Related]
13. A new series of semisynthetic rifamycins. N derivatives of 4-amino-4-deoxyrifamycin SV. Cricchio R; Tamborini G J Med Chem; 1971 Aug; 14(8):721-3. PubMed ID: 4398855 [No Abstract] [Full Text] [Related]
14. [In vitro antibacterial activity of tetracycline, oleandomycin and their combination on 836 bacterial strains]. Liani M; Renzini G; Dominici A Antibiotica; 1969 Sep; 7(3):219-33. PubMed ID: 4948395 [No Abstract] [Full Text] [Related]
15. [Gentamicin. Brief review of current information]. Modr Z; Hejzlar M Cas Lek Cesk; 1970 Apr; 109(17):347-51. PubMed ID: 4393373 [No Abstract] [Full Text] [Related]
16. Brief exposure of bacteria to topical antibiotics. Scherr DD; Dodd TA Surg Gynecol Obstet; 1973 Jul; 137(1):87-90. PubMed ID: 4351660 [No Abstract] [Full Text] [Related]